UNSPSC 51101914: Artesunate

This classification denotes an antiprotozoal agent with the molecular formula C19H28O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60W3249T9M, chemically known as 4-oxo-4-(((3r,5as,6r,8as,9r,10s,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate but generally known as artesunate, which bears US NIH Compound Identifier 65664. European Medicines Agency schedules Artesunate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05576MIG.

UNSPSC 51101914 Artesunate is a Commodity code that covers pharmaceutical products supplied through state and local health and safety procurement channels. Recent state and local solicitations tagged under this code show purchases of antimalarial and emergency-response pharmaceuticals, though the tagging does not consistently match the code's nominal scope — the opportunities shown involve naloxone, drug deactivation systems, and fluoroquinolone and tetracycline antibiotics rather than artesunate specifically. State and local health departments and county public health authorities are the primary issuing bodies, procuring pharmaceuticals through competitive bidding processes (IFB) and piggyback awards under multi-state consortiums such as MMCAP Infuse. The work involves securing supply contracts for emergency medicines and public health interventions, typically with multi-year terms and quarterly or as-needed delivery schedules to county health facilities or state stockpiles.

The Illinois Department of Public Health and Seminole County, Florida represent the geographic footprint of recent activity. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, supplying Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets over 12 months with renewal options for years 2 and 3 under an Invitation for Bid process. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, on a two-year initial term with one-year renewal option; the response deadline was July 26, 2023 (likely a data-entry error in the source). Both procurements included E-Verify compliance, drug-free workplace certification, and insurance requirements, and neither specified explicit set-aside designations for disadvantaged enterprises.